MyFinsight
Home
Blog
About
Back
Income Statement
Liminatus Pharma, Inc. (LIMNW)
Liminatus Pharma, Inc. (LIMNW)
source: myfinsight.com
Net income (loss)
-$1,407,259
(-1342.21%↓ Y/Y)
Loss from operations
-$1,378,908
(-23.31%↓ Y/Y)
Total other income
(expense), net
-$28,351
(-102.30%↓ Y/Y)
Forgiveness of unrelated
vendor payables
$11,515
(-99.46%↓ Y/Y)
Interest and other income
$8,223
Total operating
expenses
$1,378,908
(23.31%↑ Y/Y)
Change in the fair value
of warrant...
$29,245
(-74.98%↓ Y/Y)
Interest expense,
related parties
$18,844
(-69.75%↓ Y/Y)
General and
administrative
$778,908
(-30.34%↓ Y/Y)
Research and development
$600,000
Back